BioNTech SE Sponsored ADR (BNTX) shares ended the last trading session 6% higher at $102.34. The jump came on an impressive volume with a higher-than-average number of shares changing hands in the ...

BioNTech saw its share price increase by 11%, coinciding with significant market activity and major index gains. While the company itself did not have any significant news or announcements within ...

BioNTech SE (NASDAQ:BNTX – Free Report) – Research analysts at HC Wainwright increased their Q1 2025 earnings estimates for shares of BioNTech in a note issued to investors on Tuesday ...

In a report released today, Tazeen Ahmad from Bank of America Securities reiterated a Buy rating on BioNTech SE (BNTX – Research Report), with ...

View Our Latest Stock Report on BioNTech BioNTech Stock Down 0.2 % NASDAQ BNTX opened at $86.65 on Wednesday. BioNTech SE has a 1-year low of $76.53 and a 1-year high of $131.49. The company has a ...

Morgan Stanley analyst Terence Flynn maintained a Buy rating on BioNTech SE (BNTX – Research Report) today and set a price target of $140.00.

As in previous studies, the SHIELD study found health care workers who received the Novavax vaccine reported significantly ...

Novavax (NasdaqGS:NVAX) recently announced promising preliminary results from the SHIELD-Utah study, which highlighted fewer and less severe reactogenicity symptoms for its COVID-19 Vaccine, ...

April 15, 2025 /PRNewswire/ -- Novavax, Inc. (Nasdaq: NVAX) today announced preliminary ... when compared with the Pfizer-BioNTech mRNA 2024-2025 vaccine. This real-world study conducted between ...

BioNTech (NasdaqGS:BNTX) saw its share price increase by 11%, coinciding with significant market activity and major index gains. While the company itself did not have any significant news or ...